NVO compared with IQV: revenue, margins and what each company keeps, and the suppliers and customers both name

NVONovo Nordisk A S

Mkt capRevenueRevenue

IQVIqvia Holdings Inc.

Mkt capRevenueRevenue

Compare

NVONovo Nordisk A S

IQVIqvia Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

NVO, solidIQV, dashed

Supply-chain overlap

Revenue flow

NVO: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NVO 6

OMEROmerossupplier

LXRXLexicon Pharmaceuticalssupplier

COAGHemab Therapeuticscustomer

VTVTvTv Therapeuticscustomer

2 more · NVO chain ›

Shared 0

No shared counterparties.

Only IQV 1

VSTMVerastemcustomer

Role chip = supplier or customerSource: SEC EDGAR

NVONovo Nordisk A S

39.98▲+2.15%· post 39.94

Mkt cap$178.6BRevenue—Revenue—

IQVIqvia Holdings Inc.

266.82▼−3.00%· post 267.50

ClosedOct 30 '26

Mkt cap$44.1BRevenue$4.4BQ3 FY26Revenue$16.3BFY25

Compare

ClosedOct 30 '26

NVONovo Nordisk A S

IQVIqvia Holdings Inc.

39.98▲+2.15%post 39.94

Price

266.82▼−3.00%post 267.50

$178.6B

Mkt cap

$44.1B

—

Revenue

$4.4BQ3 FY26

—

Revenue

$16.3BFY25

NVO39.98▲+2.15%vsIQV266.82▼−3.00%ClosedOct 30 '26